BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 29524315)

  • 1. Serum calcitonin negative mixed medullary-follicular carcinoma initially diagnosed as medullary thyroid carcinoma by fine-needle aspiration cytology: A case report and review of the literatures.
    Liu Y; Yuan L; Yang D; Jin Y
    Diagn Cytopathol; 2018 Aug; 46(8):690-693. PubMed ID: 29524315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of fine-needle aspirate calcitonin to detect medullary thyroid carcinoma: A systematic review.
    Trimboli P; Guidobaldi L; Bongiovanni M; Crescenzi A; Alevizaki M; Giovanella L
    Diagn Cytopathol; 2016 Jan; 44(1):45-51. PubMed ID: 26481456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcitonin levels in washout samples vs. cytology in the detection of malignant lymph node metastasis in recurrent medullary thyroid cancer.
    Gökçay Canpolat A; Şahin M; Ceyhan K; Sak S; Demir Ö; Emral R; Erdoğan MF; Güllü S; Çorapçıoğlu D
    Turk J Med Sci; 2021 Dec; 51(6):3061-3066. PubMed ID: 34519193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fine-needle aspiration cytology for medullary thyroid carcinoma: a single institutional experience in Japan.
    Suzuki A; Hirokawa M; Takada N; Higuchi M; Ito A; Yamao N; Hayashi T; Kuma S; Miyauchi A
    Endocr J; 2017 Nov; 64(11):1099-1104. PubMed ID: 28883261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An old friend, a new insight: Calcitonin measurement in serum and aspiration needle washout fluids significantly increases the early and accurate detection of medullary thyroid cancer.
    Ogmen BE; Ince N; Aksoy Altınboga A; Akdogan L; Polat SB; Genc B; Menekse E; Aydin C; Topaloglu O; Ersoy R; Cakir B
    Cancer Cytopathol; 2024 Mar; 132(3):161-168. PubMed ID: 37950525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of Serum Calcitonin in Patients Without a Suspicious History of Medullary Thyroid Carcinoma and with Thyroid Nodules Without an Indication for Fine-Needle Aspiration or with Benign Cytology.
    Rosario PW; Calsolari MR
    Horm Metab Res; 2016 Jun; 48(6):372-276. PubMed ID: 27203410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimizing Diagnostic Accuracy of Fine Needle Aspiration Biopsy Calcitonin Measurements in Detecting Medullary Thyroid Carcinoma.
    Cavallo AC; Pitoia F; Roberti J; Brenzoni P; Lencioni M; Jaroslavsky MJ; Spengler E; Voogd A; Firpo C; Saco P; Piñero F; Negueruela M
    Thyroid; 2024 Feb; 34(2):186-196. PubMed ID: 38047535
    [No Abstract]   [Full Text] [Related]  

  • 8. Multiple Endocrine Neoplasia Type 2B Associated Mixed Medullary and Follicular Thyroid Carcinoma in A Chinese Patient with RET M918T Germline Mutation.
    Qi XP; Lin GB; Chen B; Li F; Cao ZL; Zheng WH; Zhao JQ
    Endocr Metab Immune Disord Drug Targets; 2021; 21(3):554-560. PubMed ID: 32660411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum markers measured in FNA fluids of medullary thyroid carcinoma occurring as a cyst.
    Trimboli P; Guidobaldi L; Locuratolo N; Piro FR; Giordano M; Giovanella L
    Int J Biol Markers; 2016 May; 31(2):e224-7. PubMed ID: 27032378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performing Calcitonin Immunocytochemistry on an Additional ThinPrep Slide in Fine-Needle Aspiration Diagnosis of Medullary Thyroid Carcinoma.
    Ahmed M; Abi-Raad R; Fu L; Holt EH; Adeniran AJ; Cai G
    Am J Clin Pathol; 2022 Mar; 157(3):426-433. PubMed ID: 34596209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relevance of immunocytochemistry on thin-layer cytology in thyroid lesions suspicious for medullary carcinoma: a case-control study.
    Rossi ED; Raffaelli M; Mulè A; Zannoni GF; Pontecorvi A; Santeusanio G; Minimo C; Fadda G
    Appl Immunohistochem Mol Morphol; 2008 Dec; 16(6):548-53. PubMed ID: 18685492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fine needle aspiration cytology of mixed medullary-follicular thyroid carcinoma: a case report.
    Hsieh MH; Lin MC; Shun CT; Chang TC
    Acta Cytol; 2008; 52(3):361-5. PubMed ID: 18540307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The variable pathologic presentations of medullary and micro-medullary thyroid carcinoma: an institutional experience.
    Samulski TD; Livolsi VA; Montone K; Baloch Z
    Pathol Res Pract; 2014 Mar; 210(3):182-5. PubMed ID: 24440099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytologic diagnosis of medullary thyroid carcinoma in the Asia-Pacific region.
    Liu CY; Bychkov A; Agarwal S; Zhu Y; Hang JF; Lai CR; Na HY; Li W; Liu Z; Jain D; Suzuki A; Hirokawa M; Chia N; Nga ME; Jitpasutham T; Keelawat S; Park SY; Satoh S; Chen CC; Gunawardena D; Kumarasinghe P; Jung CK; Kakudo K
    Diagn Cytopathol; 2021 Jan; 49(1):60-69. PubMed ID: 32827355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of sporadic medullary thyroid carcinoma: the importance of routine measurement of serum calcitonin in the diagnostic evaluation of thyroid nodules.
    Rieu M; Lame MC; Richard A; Lissak B; Sambort B; Vuong-Ngoc P; Berrod JL; Fombeur JP
    Clin Endocrinol (Oxf); 1995 May; 42(5):453-60. PubMed ID: 7621562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Head-to-head comparison of FNA cytology vs. calcitonin measurement in FNA washout fluids (FNA-CT) to diagnose medullary thyroid carcinoma. A systematic review and meta-analysis.
    Trimboli P; Giannelli J; Marques B; Piccardo A; Crescenzi A; Deandrea M
    Endocrine; 2022 Jan; 75(1):33-39. PubMed ID: 34606057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic value and cost-effectiveness of FNA-CT versus FNAC for medullary thyroid carcinoma.
    Wang M; Chen H; Wang Y; Lei J; Li Z
    Clin Endocrinol (Oxf); 2023 May; 98(5):709-718. PubMed ID: 36394172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. False-positive staining of thyroglobulin distinguished from mixed medullary and follicular thyroid carcinoma by duplex in situ hybridization.
    Takeshima K; Ariyasu H; Uraki S; Morita S; Furukawa Y; Inaba H; Iwakura H; Doi A; Warigaya K; Murata SI; Enomoto K; Hotomi M; Akamizu T
    Endocr J; 2020 Oct; 67(10):1007-1017. PubMed ID: 32522910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and pathologic characteristics of medullary thyroid carcinoma-review of current guidelines.
    Thomas CM; Asa SL; Ezzat S; Sawka AM; Goldstein D
    Curr Oncol; 2019 Oct; 26(5):338-344. PubMed ID: 31708652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mixed follicular-medullary thyroid carcinoma: a case report.
    Luboshitzky R; Dharan M
    Diagn Cytopathol; 2004 Feb; 30(2):122-4. PubMed ID: 14755766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.